Liposomal enhanced intra-peritoneal chemotherapy

A method of treating a neoplasm in a subject comprising intraperitoneally instilling in the subject a liposomal formulation comprising liposomes, wherein the liposomes consist of:

• (a) a taxane drug;
• (b) dimyristoyl phosphatidylcholine (DMPC);
• and
• (c) dimyristoyl phosphatidyl glycerol sodium (DMPG),
• wherein the weight/weight/weight (w/w/w) ratios of (a):(b):(c) are (1):(1.3-4.5):(0.4-2.5), for a sufficient intraperitoneal dwell time and in an effective amount to inhibit growth of the neoplasm, wherein the neoplasm is an ovarian cancer neoplasm, a malignant sex cord-stromal tumor, carcinomatosis neoplasm of the ovary, a malignant germ cell neoplasm, an ovarian low malignant (LMP) tumor, a fallopian tube cancer neoplasm, or a primary peritoneal cancer neoplasm.